Drawing for BIFIFOLIC

USPTO serial 79036294

BIFIFOLIC

Reviewed by CopyMark Law Group

Reg. 3409418Status 404
Filing date
Status date
Registration date
Apr 8, 2008
Examiner
GENOVESE, CARRIE A
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIFIFOLIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John P. Murtaugh

John P. Murtaugh Pearne & Gordon LLP1801 East 9th Street, Suite 1200Cleveland, OH 44114-3108UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and cultures of micro-organisms, in particular bacteria and bifidobacteria; fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and cultures of micro-organisms, in particular probiotic lactic acid bacteria, probiotic bifidobacteria for administering to humans and to animal livestock species, not for medical or veterinary use; fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried or freeze-dried formSECTION 71 - CANCELLED—
005Bacterial and bacteriological preparations for medical or veterinary purposes, namely, micro-organisms and cultures of micro-organisms, in particular probiotic lactic acid bacteria and probiotic bifidobacteria for administering to humans and to animal livestock species; proprietary medicines for the treatment or elimination of bacteria, fungi and viruses present in tissue, on the skin and in mucous membranes, containing micro-organisms and cultures of micro-organisms; food supplements, food supplements for medical use containing micro-organisms or cultures of microorganisms, in particular probiotic lactic acid bacteria, probiotic bifidobacteria for administering to humans; dietetic supplements; proprietary medicines containing lactic acid bacteria and bifidobacteria, in particular lactic ferments, probiotic micro-organisms or cultures of micro-organisms, for the treatment of intestinal bacterial flora, to restore the balance of intestinal bacterial flora altered during courses of antibiotic therapy or chemotherapy, for the treatment of acute and chronic gastro-intestinal problems caused by an alteration in the intestinal bacterial flora, for the treatment of intestinal dismicrobian syndromes, in particular in pathologies linked to alterations in bacterial flora such as diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, for the production of vitamins, in particular of vitamin B12 or folic acid in the gastro-intestinal segment, and for stimulating intestinal bacterial flora to produce vitamins, in particular vitamin B12 or folic acid, all in the forms of capsules, tablets, solutions, suspensions, granules, or granules in dried or freeze-dried formSECTION 71 - CANCELLED—
029Fermented products and milk, namely, yogurt, cheese, milk and soy-based food beverage for use as a milk substitute, rice milk for use as a milk substitute; proteins being foodstuffs for human consumption, not for medical use, containing micro-organisms and micro-organism cultures, in particular probiotic lactic acid bacteria and probiotic bifidobacteria; proteins being foodstuffs for human consumption containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic acid bacteria, probiotic bifidobacteria and prebiotic fibersSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 3, 2017DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Aug 3, 2017DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 17, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 18, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 25, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 25, 2015INPCINVALIDATION PROCESSED—
Jul 28, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 28, 2014C71TCANCELLED SECTION 71—
Nov 27, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 14, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 2, 2008NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 25, 2008NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 29, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 29, 2008FIMPFINAL DISPOSITION PROCESSED—
Jul 10, 2008CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jul 8, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 8, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 22, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 2, 2008NPUBNOTICE OF PUBLICATION—
Dec 20, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 20, 2007ALIEASSIGNED TO LIE—
Nov 12, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 9, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 9, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 5, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 5, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 25, 2007RFNTREFUSAL PROCESSED BY IB—
May 9, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 9, 2007RFRRREFUSAL PROCESSED BY MPU—
May 9, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 8, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2007DOCKASSIGNED TO EXAMINER—
Apr 27, 2007NWAPNEW APPLICATION ENTERED—
Apr 26, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance